Traws Pharma (TRAW) Change in Account Payables (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Change in Account Payables of $2.0 million for Q1 2026, up 432.56% year-over-year from $377796.4 in Q1 2025, and down 18.51% quarter-over-quarter from $2.5 million in Q4 2025.
Traws Pharma (TRAW) Change in Account Payables (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Change in Account Payables for 15 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 432.56% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (up 320.81% YoY), while the FY2025 annual figure was -$612000.0, down 194.74% from the prior year.
- Change in Account Payables retreated to $2.0 million in Q1 2026 per TRAW's latest filing, from $2.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.5 million in Q4 2025 and bottomed at -$3.0 million in Q2 2025.
- Historically, Change in Account Payables has averaged $288705.9 across 5 years, with a median of $365000.0 in 2022.
- Annual changes were most pronounced in 2025 — Change in Account Payables slumped 661.42% — and 2026, when it surged 432.56%.
- Traws Pharma's Change in Account Payables stood at $100000.0 in 2022, then sank by 629.0% to -$529000.0 in 2023, then surged by 249.91% to $793000.0 in 2024, then surged by 211.35% to $2.5 million in 2025, then retreated by 18.51% to $2.0 million in 2026.
- Business Quant data shows TRAW's Change in Account Payables at $2.0 million in Q1 2026, $2.5 million in Q4 2025, and $524000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - | -1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.01 Mn |
| Mar 31, 2026 | 2.01 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 524,000.00 |
| Sep 30, 2025 | 524,000.00 |
| Jun 30, 2025 | -3.00 Mn |
| Jun 30, 2025 | -3.00 Mn |
| Mar 31, 2025 | -605,000.00 |
| Mar 31, 2025 | -605,000.00 |
| Dec 31, 2024 | 793,000.00 |
| Dec 31, 2024 | 793,000.00 |
| Sep 30, 2024 | -702,000.00 |
| Sep 30, 2024 | -702,000.00 |
| Jun 30, 2024 | -394,000.00 |
| Jun 30, 2024 | -394,000.00 |
| Mar 31, 2024 | 949,000.00 |
| Mar 31, 2024 | 949,000.00 |
| Dec 31, 2023 | -529,000.00 |
| Dec 31, 2023 | -529,000.00 |